美国青蒿素酸市场规模、份额和趋势分析报告：按产品和细分市场预测（2025-2033 年）

美国青蒿素酸市场摘要

2024年美国青蒿素酸市场规模估计为2.366亿美元，预计2033年将达到3.677亿美元。

预计从 2025 年到 2033 年，该市场将以 5.0% 的复合年增长率成长。美国青蒿素酸市场的主要成长要素包括：与国际旅行相关的疟疾病例增加、全球对传统抗疟疾药的抗药性日益增强、政府支持的储备倡议以及半合成生产方法的研究和开发不断扩大。

非洲和东南亚地区恶性疟疾原虫对传统抗疟疾药抗药性株的出现，促使医疗机构和政策制定者优先考虑快速起效的青蒿素类药物治疗。随着抗药性模式的演变，美国越来越依赖效力更强的青蒿素製剂，推动进口、研发投资和有效治疗药物储备，以确保能够应对毒性更强的疟疾。

此外，基因改造酵母（酿酒酵母）等生物技术创新使得青蒿素酸的生产更加可靠和大规模，从而减少了对易受气候变迁和产量波动影响的艾蒿（青蒿）等农业原料的依赖。随着製药公司采用这些方法，美国市场将受益于更可靠、更具成本效益的生产，从而支援更广泛的分销和紧急准备。

目录

第一章调查方法和范围

第二章执行摘要

第三章美国青蒿素酸市场趋势及展望

• 市场体系展望
  • 母市场
  • 子公司市场
• 市场动态
  • 市场驱动因素分析
  • 市场限制因素分析
• 美国青蒿素酸市场分析工具
  • 产业分析—波特五力分析
  • PESTEL 分析
  • 法律规范

第四章美国青蒿素酸市场：依产品分類的估算与趋势分析

• 细分仪表板
• 美国青蒿素酸市场：按产品分類的波动分析
• 美国青蒿素酸市场规模及趋势分析（依产品分类，2021-2033 年）
• 抗疟疾药片
• 抗疟疾注射剂

第五章 竞争情势

• 市场参与企业分类
• 企业市场分析/堆图分析
• 公司简介
  • Sanofi
  • KPC Pharmaceuticals, Inc.
  • Guilin Pharmaceuticals Co,. Ltd.
  • Calyx Chemicals and Pharmaceuticals Ltd.
  • Novartis Pharmaceuticals Corporation
  • Ipca Laboratories Inc.
  • Cipla USA Inc.
  • SHINPOONG CO. Ltd.

U.S. Artemisinic Acid Market Summary

The U.S. artemisinic acid market size was estimated at USD 236.6 million in 2024 and is projected to reach USD 367.7 million by 2033, growing at a CAGR of 5.0% from 2025 to 2033. The primary factors driving the U.S. artemisinic acid market include an increase in malaria cases connected to international travel, the rising global resistance to traditional antimalarials, government-supported stockpiling initiatives, and expanded research and development in semi-synthetic production methods.

The rise of Plasmodium falciparum strains resistant to traditional antimalarial drugs in Africa and Southeast Asia is prompting healthcare providers and policymakers to prioritize access to fast-acting artemisinin-based treatments. As resistance patterns evolve, U.S. institutions increase their reliance on advanced artemisinic formulations, driving imports, R&D investment, and stockpiling of effective therapies to ensure readiness against more virulent malaria forms.

Furthermore, biotechnology innovations such as engineered Saccharomyces cerevisiae (yeast)-have enabled more stable and scalable production of artemisinic acid. This reduces reliance on agricultural sources such as Artemisia annua, vulnerable to climate and yield variability. As pharmaceutical companies adopt these methods, the U.S. market benefits from enhanced production reliability and cost-efficiency, supporting broader distribution and emergency preparedness.

U.S. Artemisinic Acid Market Report Segmentation

This report forecasts revenue growth at U.S. artemisinic acid market and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. artemisinic acid market report based on product.

• Product Outlook (Revenue, USD Million, 2021 - 2033)
• Antimalarial Injections
• Antimalarial Tablets

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased Database
  • 1.3.2. GVR's Internal Database
  • 1.3.3. Secondary Sources
  • 1.3.4. Primary Research
• 1.4. Information/Data Analysis
• 1.5. Market Formulation & Visualization
• 1.6. Data Validation & Publishing
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis
  • 1.7.2. U.S. Market: CAGR Calculation
• 1.8. List of Secondary Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Artemisinic Acid Market Variable Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market
  • 3.1.2. Ancillary Market
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Market Restraint Analysis
• 3.3. U.S. Artemisinic Acid Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitution
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal landscape
    • 3.3.2.2. Economic and Social landscape
    • 3.3.2.3. Technological landscape
    • 3.3.2.4. Environmental landscape
  • 3.3.3. Regulatory Framework

Chapter 4. U.S. Artemisinic Acid Market: Product Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Artemisinic Acid Market: Product Movement Analysis
• 4.3. U.S. Artemisinic Acid Market Size & Trend Analysis, by product, 2021 to 2033 (USD Million)
• 4.4. Antimalarial Tablets
  • 4.4.1. Antimalarial Tablets Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Antimalarial Injections
  • 4.5.1. Antimalarial Injections Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Competitive Landscape

• 5.1. Market Participant Categorization
• 5.2. Company Market Position Analysis/ Heap Map Analysis
• 5.3. Company Profiles
  • 5.3.1. Sanofi
    • 5.3.1.1. Participant's Overview
    • 5.3.1.2. Financial Performance
    • 5.3.1.3. Product Benchmarking
    • 5.3.1.4. Strategic Initiatives
  • 5.3.2. KPC Pharmaceuticals, Inc.
    • 5.3.2.1. Participant's Overview
    • 5.3.2.2. Financial Performance
    • 5.3.2.3. Product Benchmarking
    • 5.3.2.4. Strategic Initiatives
  • 5.3.3. Guilin Pharmaceuticals Co,. Ltd.
    • 5.3.3.1. Participant's Overview
    • 5.3.3.2. Financial Performance
    • 5.3.3.3. Product Benchmarking
    • 5.3.3.4. Strategic Initiatives
  • 5.3.4. Calyx Chemicals and Pharmaceuticals Ltd.
    • 5.3.4.1. Participant's Overview
    • 5.3.4.2. Financial Performance
    • 5.3.4.3. Product Benchmarking
    • 5.3.4.4. Strategic Initiatives
  • 5.3.5. Novartis Pharmaceuticals Corporation
    • 5.3.5.1. Participant's Overview
    • 5.3.5.2. Financial Performance
    • 5.3.5.3. Product Benchmarking
    • 5.3.5.4. Strategic Initiatives
  • 5.3.6. Ipca Laboratories Inc.
    • 5.3.6.1. Participant's Overview
    • 5.3.6.2. Financial Performance
    • 5.3.6.3. Product Benchmarking
    • 5.3.6.4. Strategic Initiatives
  • 5.3.7. Cipla USA Inc.
    • 5.3.7.1. Participant's Overview
    • 5.3.7.2. Financial Performance
    • 5.3.7.3. Product Benchmarking
    • 5.3.7.4. Strategic Initiatives
  • 5.3.8. SHINPOONG CO. Ltd.
    • 5.3.8.1. Participant's Overview
    • 5.3.8.2. Financial Performance
    • 5.3.8.3. Product Benchmarking
    • 5.3.8.4. Strategic Initiatives

List of Tables

• Table 1 List of secondary sources
• Table 2 U.S. Artemisinic Acid Market, by Product, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 Market segmentation
• Fig. 2 Market research process
• Fig. 3 Information procurement
• Fig. 4 Primary research pattern
• Fig. 5 Market research approaches
• Fig. 6 Value chain-based sizing & forecasting
• Fig. 7 QFD modelling for market share assessment
• Fig. 8 Market formulation & validation
• Fig. 9 U.S. artemisinic acid market revenue, 2021 - 2033 (USD Million)
• Fig. 10 U.S. artemisinic acid market snapshot
• Fig. 11 U.S. artemisinic acid market driver impact
• Fig. 12 U.S. artemisinic acid market restraint impact
• Fig. 13 U.S. artemisinic acid market product key takeaways (USD Million)
• Fig. 14 U.S. artemisinic acid market : Product movement analysis
• Fig. 15 Antimalarial injections market, 2021 - 2033 (USD Million)
• Fig. 16 Antimalarial tablets market, 2021 - 2033 (USD Million)
• Fig. 17 Market participant categorization